Your unfortunately dreaming of best case scenario. I seen many studies done similar to flu vaccine where they anticipate that once there is enough Vaccines available for say 200 million which won’t be until mid next year that’s only 100 million people since they will need 2 each and that would be about 30 of US population it won’t be as effective as there very inconclusive study so 80% of population will still be at risk and still spreading it, I know many people that will not take the vaccine because they have zero trust in the FDA and are more worried of the side effects. Therapeutics will be greatly needed US and abroad thorough out all of next year and most likely beyond. I understand leronlimab will be needed more in other countries but it doesn’t mean that US won’t take first stab at buying up all inventory.